Acambis brings smallpox vaccine production in-house
UK biotech firm Acambis has decided to bring the manufacturing of its soon to be approved smallpox vaccine in-house while its agreement with contract manufacturer Baxter comes to an end.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs